These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

728 related items for PubMed ID: 9551923

  • 1. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen.
    Davis HL, Weeratna R, Waldschmidt TJ, Tygrett L, Schorr J, Krieg AM.
    J Immunol; 1998 Jan 15; 160(2):870-6. PubMed ID: 9551923
    [Abstract] [Full Text] [Related]

  • 2. CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice.
    Weeratna RD, Brazolot Millan CL, McCluskie MJ, Davis HL.
    FEMS Immunol Med Microbiol; 2001 Dec 15; 32(1):65-71. PubMed ID: 11750224
    [Abstract] [Full Text] [Related]

  • 3. Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen.
    Mutwiri G, Benjamin P, Soita H, Babiuk LA.
    Vaccine; 2008 May 23; 26(22):2680-8. PubMed ID: 18430493
    [Abstract] [Full Text] [Related]

  • 4. CpG DNA is an effective oral adjuvant to protein antigens in mice.
    McCluskie MJ, Weeratna RD, Krieg AM, Davis HL.
    Vaccine; 2000 Nov 22; 19(7-8):950-7. PubMed ID: 11115721
    [Abstract] [Full Text] [Related]

  • 5. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
    Wild J, Grusby MJ, Schirmbeck R, Reimann J.
    J Immunol; 1999 Aug 15; 163(4):1880-7. PubMed ID: 10438922
    [Abstract] [Full Text] [Related]

  • 6. Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses.
    Bian G, Cheng Y, Wang Z, Hu Y, Zhang X, Wu M, Chen Z, Shi B, Sun S, Shen Y, Chen EJ, Yao X, Wen Y, Yuan Z.
    Vaccine; 2009 Dec 10; 28(1):187-94. PubMed ID: 19789093
    [Abstract] [Full Text] [Related]

  • 7. Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA.
    McCluskie MJ, Weeratna RD, Payette PJ, Davis HL.
    FEMS Immunol Med Microbiol; 2002 Feb 18; 32(3):179-85. PubMed ID: 11934561
    [Abstract] [Full Text] [Related]

  • 8. Plasmids enriched with CpG motifs activate human peripheral blood mononuclear cells in vitro and enhance th-1 immune responses to hepatitis B surface antigen in mice.
    Chen Z, Cao J, Liao X, Ke J, Zhu S, Zhao P, Qi Z.
    Viral Immunol; 2011 Jun 18; 24(3):199-209. PubMed ID: 21668361
    [Abstract] [Full Text] [Related]

  • 9. Priming of immune responses to hepatitis B surface antigen in young mice immunized in the presence of maternally derived antibodies.
    Weeratna RD, Brazolot Millan CL, McCluskie MJ, Siegrist CA, Davis HL.
    FEMS Immunol Med Microbiol; 2001 Apr 18; 30(3):241-7. PubMed ID: 11335145
    [Abstract] [Full Text] [Related]

  • 10. Oligodeoxynucleotides containing synthetic immunostimulatory motifs augment potent Th1 immune responses to HBsAg in mice.
    Li Y, Kandimalla ER, Yu D, Agrawal S.
    Int Immunopharmacol; 2005 Jun 18; 5(6):981-91. PubMed ID: 15829414
    [Abstract] [Full Text] [Related]

  • 11. The potential of oligodeoxynucleotides as mucosal and parenteral adjuvants.
    McCluskie MJ, Weeratna RD, Davis HL.
    Vaccine; 2001 Mar 21; 19(17-19):2657-60. PubMed ID: 11257405
    [Abstract] [Full Text] [Related]

  • 12. [Impact of different adjuvants on immunogenicity of the HBV particle vaccine containing the S + preS1 fusion antigen in Balb/C mice].
    Chen H, Deng Y, Tan W, Wang W, Yin X, Guan J, Wang W, Ruan L.
    Sheng Wu Gong Cheng Xue Bao; 2010 Jan 21; 26(1):74-8. PubMed ID: 20353095
    [Abstract] [Full Text] [Related]

  • 13. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity.
    Chu RS, Targoni OS, Krieg AM, Lehmann PV, Harding CV.
    J Exp Med; 1997 Nov 17; 186(10):1623-31. PubMed ID: 9362523
    [Abstract] [Full Text] [Related]

  • 14. Immunostimulatory CpG motifs trigger a T helper-1 immune response to human immunodeficiency virus type-1 (HIV-1) gp 160 envelope proteins.
    Deml L, Schirmbeck R, Reimann J, Wolf H, Wagner R.
    Clin Chem Lab Med; 1999 Mar 17; 37(3):199-204. PubMed ID: 10353461
    [Abstract] [Full Text] [Related]

  • 15. Enhanced tumor-specific long-term immunity of hemagglutinating [correction of hemaggluttinating] virus of Japan-mediated dendritic cell-tumor fused cell vaccination by coadministration with CpG oligodeoxynucleotides.
    Hiraoka K, Yamamoto S, Otsuru S, Nakai S, Tamai K, Morishita R, Ogihara T, Kaneda Y.
    J Immunol; 2004 Oct 01; 173(7):4297-307. PubMed ID: 15383558
    [Abstract] [Full Text] [Related]

  • 16. CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice.
    McCluskie MJ, Davis HL.
    J Immunol; 1998 Nov 01; 161(9):4463-6. PubMed ID: 9794366
    [Abstract] [Full Text] [Related]

  • 17. Intranasal immunization of mice with CpG DNA induces strong systemic and mucosal responses that are influenced by other mucosal adjuvants and antigen distribution.
    McCluskie MJ, Weeratna RD, Davis HL.
    Mol Med; 2000 Oct 01; 6(10):867-77. PubMed ID: 11126201
    [Abstract] [Full Text] [Related]

  • 18. Testing of CpG-optimized protein and DNA vaccines against the hepatitis B virus in chimpanzees for immunogenicity and protection from challenge.
    Payette PJ, Ma X, Weeratna RD, McCluskie MJ, Shapiro M, Engle RE, Davis HL, Purcell RH.
    Intervirology; 2006 Oct 01; 49(3):144-51. PubMed ID: 16428890
    [Abstract] [Full Text] [Related]

  • 19. T helper 2 immunity to hepatitis B surface antigen primed by gene-gun-mediated DNA vaccination can be shifted towards T helper 1 immunity by codelivery of CpG motif-containing oligodeoxynucleotides.
    Zhou X, Zheng L, Liu L, Xiang L, Yuan Z.
    Scand J Immunol; 2003 Sep 01; 58(3):350-7. PubMed ID: 12950682
    [Abstract] [Full Text] [Related]

  • 20. Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract.
    Gallichan WS, Woolstencroft RN, Guarasci T, McCluskie MJ, Davis HL, Rosenthal KL.
    J Immunol; 2001 Mar 01; 166(5):3451-7. PubMed ID: 11207303
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.